JF
STOK icon

Jump Financial’s Stoke Therapeutics STOK Stock Holding History

Jump Financial’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-34,277
Closed -$463K – 2096
2024
Q2 		$463K Buy
+34,277
New +$463K 0.01% 1166
2023
Q1 		– Sell
-15,552
Closed -$144K – 2041
2022
Q4 		$144K Buy
15,552
+5,552
+56% +$57.7K 0.01% 1363
2022
Q3 		$128K Sell
10,000
-24,700
-71% -$394K 0.01% 1418
2022
Q2 		$458K Buy
34,700
+19,850
+134% +$302K 0.02% 895
2022
Q1 		$312K Buy
+14,850
New +$297K 0.01% 1051
2021
Q3 		– Sell
-10,200
Closed -$343K – 1485
2021
Q2 		$343K Buy
10,200
+1,266
+14% +$44.8K 0.03% 615
2021
Q1 		$347K Buy
+8,934
New +$509K 0.03% 556

Other funds holding STOK

ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jump Financial's STOK Position: Q3 2024 in Review

Jump Financial sold out of Stoke Therapeutics (STOK) in Q3 2024, closing a stake of 34,277 shares — an estimated $463K sold.

Jump Financial first reported a position in STOK in Q1 2021 and held it in 7 quarters. The position peaked at $463K in Q2 2024. 118 funds tracked by Wall St. Rank hold STOK as of Q3 2024.

  • Jump Financial reported no remaining Stoke Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 34,277 Stoke Therapeutics shares in Q3 2024, an estimated $463K.
  • Jump Financial first reported a position in Stoke Therapeutics in Q1 2021 and held it in 7 quarters.
  • Jump Financial's Stoke Therapeutics position peaked at $463K in Q2 2024.
  • 118 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.